Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
COVID-19
Type of publications
Guidelines (1)
NITAG documentation (354)
SAGE documentation (33)
Scientific publications (4)
Systematic reviews (SYSVAC) (1089)
Regions
Africa (57)
Americas (187)
Eastern Mediterranean (10)
Europe (155)
South-East Asia (10)
Western Pacific (36)
Diseases
COVID-19 (1481)
Chikungunya (9)
Cholera (33)
Cytomegalovirus (1)
Dengue (39)
Diphtheria (79)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (66)
Hepatitis A (63)
Hepatitis B (153)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (66)
HIV / AIDS (10)
Human papillomavirus (HPV) (472)
Influenza (573)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (27)
Measles (128)
Meningococcal disease (145)
Mpox (55)
Mumps (46)
Pertussis (104)
Pneumococcal disease (266)
Poliomyelitis (84)
Q fever (1)
Rabies (28)
Rotavirus (115)
RSV (Respiratory syncytial virus) (47)
Rubella (64)
Salmonella (2)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (59)
Tick-borne encephalitis (12)
Tuberculosis (73)
Typhoid (23)
Varicella (69)
Yellow fever (42)
Zika (1)
Show more
Methodological quality (AMSTAR 2)
High (12)
Moderate (7)
Low (111)
Critically low (685)
Not applicable (274)
1481 results found
2021
∙
ACIP
ACIP Updated Recommendations for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - 27 April 2021
2021
∙
Sara Oliver, ACIP
ACIP Work Group interpretations of data
2021
∙
UNITAG
Addendum 2 to UNITAG Report on Priority Groups to be vaccinated against COVID-19
2021
∙
ATAGI
Advice on the relative timing of administering influenza and COVID-19 vaccines in 2021
2021
∙
ACIP
AstraZeneca COVID-19 vaccine (AZD1222)
2021
∙
ATAGI
ATAGI advice on seasonal influenza vaccines in 2021 - 8 June 2021
2021
∙
ATAGI
ATAGI clinical guidance on COVID-19 vaccine in Australia - 13 April, 2021
2021
∙
ATAGI
ATAGI Guidance on Myocarditis and Pericarditis after mRNA COVID-19 vaccines - 9 August 2021
2021
∙
ATAGI
ATAGI immunisation provider guide to obtaining informed consent for COVID-19 vaccine.
2021
∙
ATAGI
ATAGI statement on SARS-CoV-2 Omicron variant and COVID-19 booster doses
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register